| Name | Title | Contact Details |
|---|
RA Capital Management (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization. RA Capital`s scientifically trained research team is intensely data driven in its continual effort to identify early breakthroughs and originate conviction in new ideas. The team`s understanding of industry best practices is derived from an extensive collection of case studies documenting the impact of clinical trial design, partnership structures, public market dynamics, and many other factors on valuation and business viability.
iM Global Partner is worldwide asset management network. It selects and builds long-term partnerships with talented and independent asset management companies through direct capital ownership. iM Global Partner is present in 11 locations across Europe and the United States and provides its clients with access to the best management strategies of its Partners. iM Global Partner`s wide range of investment solutions includes the OYSTER range, a Luxembourg SICAV, but also Mutual Funds and ETFs dedicated to US investors. The addition of Litman Gregory, a nationally recognized US wealth and asset management firm, which should be completed in May/June 2021 subject to SEC approval, will increase dramatically iM Global Partner`s US operations.
Shelter Capital Partners is one of the leading companies in the Financial Services sector.
Renaissance Capital Group is a Dallas, TX-based company in the Financial Services sector.
Marlin Equity Partners is a leading private investment firm with over $1 billion of capital under management.